The use of whole exome sequencing and murine patient derived xenografts as a method of chemosensitivity testing in sarcoma
Open Access
- 8 March 2018
- journal article
- research article
- Published by Springer Nature in Clinical Sarcoma Research
- Vol. 8 (1) , 1-8
Abstract
Soft tissue and bone sarcoma represent a broad spectrum of different pathology and genetic variance. Current chemotherapy regimens are derived from randomised trials and represent empirical treatment. Chemosensitivity testing and whole exome sequencing (WES) may offer personalized chemotherapy treatment based on genetic mutations. A pilot, prospective, non-randomised control experimental study was conducted. Twelve patients with metastatic bone or soft tissue sarcoma that had failed first line chemotherapy treatment were enrolled for this study. Human tissue taken at surgical biopsy under general anaesthetic was divided between two arms of the trial. Subsections of the tumour were used for WES and the remainder was implanted subcutaneously in immunodeficient mice (PDX). Results of WES were analysed using a bioinformatics pipeline to identify mutations conferring susceptibility to kinase inhibitors and common chemotherapeutic agents. PDX models exhibiting successful growth underwent WES of the tumour and subsequent chemosensitivity testing. WES was successful in all 12 patients, with successful establishment PDX tumours models in seven patients. WES identified potential actionable therapeutics in all patients. Significant variation in predicted therapeutics was demonstrated between three PDX samples and their matched tumour samples. Analysis of WES of fresh tumour specimens via a bioinformatics pipeline may identify potential actionable chemotherapy agents. Further research into this field may lead to the development of personalized cancer therapy for sarcoma.Keywords
Funding Information
- Abbie Basson Sarcoma Foundation Ltd
This publication has 32 references indexed in Scilit:
- Patient-derived xenografts undergo mouse-specific tumor evolutionNature Genetics, 2017
- Systemic treatment in advanced soft tissue sarcoma: what is standard, what is newBMC Medicine, 2017
- WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkitNucleic Acids Research, 2017
- UniProt: the universal protein knowledgebaseNucleic Acids Research, 2016
- Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov ModelsHuman Mutation, 2012
- What can exome sequencing do for you?Journal of Medical Genetics, 2011
- KIT gene in pediatric osteosarcomas: Could it be a new therapeutic target?International Journal of Cancer, 2007
- Distribution and intensity of constraint in mammalian genomic sequenceGenome Research, 2005
- Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex diseaseNature Genetics, 2003
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003